Prednisolone sodium phosphate 2.5 mg/ML / sulfacetamide sodium 100 mg/ML Ophthalmic Suspension [Sulster]
RxNorm 1012098
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1012098 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: prednisolone sodium phosphate 2.5 mg/ML / sulfacetamide sodium 100 mg/ML Ophthalmic Suspension [Sulster].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Prednisolone sodium phosphate 2.5 mg/ML / sulfacetamide sodium 100 mg/ML Ophthalmic Suspension [Sulster]
(Atom ID: 12359619)
TMSY
Tall Man Lettering Synonym (TMSY):
PrednisoLONE sodium phosphate 2.5 mg/ML / sulfacetamide sodium 100 mg/ML Ophthalmic Suspension [Sulster]
(Atom ID: 12377331)
SY
Synonym (SY):
Sulster (prednisolone sodium phosphate 0.25 % / sulfacetamide sodium 10 % ) Ophthalmic Suspension
(Atom ID: 3306126)
TMSY